儿童耐药性的原因和危险因素
Jafar Nasiri1, Mohammadreza Ghazzavi1, Maryam Sedghi2
1Department of Pediatric Neurology, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non- Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Iranian journal of child neurology
|August 28, 2023
概括
儿科耐火性发作与新生儿窒息和生命早期发作等出生并发症有关. 识别这些危险因素有助于对儿童耐药性的早期干预.
科学领域:
- 神经学 神经学
- 儿科神经学 儿科神经学
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 是一种全球常见的慢性神经系统疾病.
- 耐药性发作影响20-40%的儿童,导致显著的损伤.
- 了解导致儿科耐火性的因素对于有效管理至关重要.
研究的目的:
- 确定耐性发作儿童的人口和相关特征.
- 探索儿童患者抗药性的潜在危险因素.
主要方法:
- 进行了一项横截面研究.
- 评估了2至16岁的患有耐药性 (耐药性) 的儿童.
- 分析了人口统计和发作相关的特征.
主要成果:
- 患有耐火性的儿童患新生儿窒息症,产后住院,新生儿和生命早期的比率更高.
- 婴儿和症状性的病史更为普遍.
- 多态发作和脑MRI异常明显更频繁;常见的病因包括缺氧缺血损伤,脑功能失调和遗传性疾病.
结论:
- 耐火性发作源于大脑的显著结构变化.
- 早期识别风险因素可以预测耐药性.
- 这允许更积极的治疗和及时的专业干预.
相关概念视频
Arteries of the Lower Limbs
212
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
212
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
341
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
341
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Antiepileptic Drugs: Glutamate Antagonists
418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418
Antiepileptic Drugs: Sodium Channel Blockers
658
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
658
Antiepileptic Drugs: GABAergic Pathway Potentiators
453
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
453


